Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The trial record now reflects a study-status update, with its latest history entry dated 2026-10-30 and an update posted on 2026-11-02.
    Difference
    0.0%
    Check dated 2026-11-06T03:59:27.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new study-record version was added, documenting updates to the trial’s status and contact/location information.
    Difference
    0.1%
    Check dated 2026-10-30T06:33:41.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new study-record version dated 2026-10-21 updates the study status and contacts/locations, replacing the previously listed 2026-08-04 date.
    Difference
    0.1%
    Check dated 2026-10-23T08:49:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-16T08:43:39.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.0%
    Check dated 2026-10-09T07:42:28.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The history now shows a new page revision v3.7.0, replacing the previous v3.6.6, indicating an update to the study record's historical metadata.
    Difference
    0.0%
    Check dated 2026-09-18T07:58:09.000Z thumbnail image

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.